EE3 A Budget Impact Analysis of Switching From Von Willebrand Factor/Factor VIII Plasma-Derived Concentrate With 2.4-1 Ratio to the Concentrate With 1-1 Ratio for the Management of Von Willebrand Disease in Qatar
Abstract
Authors
Laila Shafei Rawan Al Froukh Amir M. Nounou Emad A. Beshay Anas Hamad